FCP
EGRX

Fidelis Capital Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Fidelis Capital Partners’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,762
Closed -$54.2K – 429
2024
Q2 		$54.2K Buy
+12,762
New +$54.2K 0.01% 373